Douglas Emmett: Leasing Recovery Meets an Acquisition Opportunity — Interest Rates Cloud the Picture
The Leasing Engine Turns
Douglas Emmett's second-quarter call was almost uniformly upbeat on the operational front. The company signed 960,000 square feet of office leases, achieved positive absorption, and saw new leases execute 3% above their expiring predecessors. “We had a very active quarter and made real progress on all 4 of our strategic priorities” — Jordan L. Kaplan, Chairman and CEO · 2026-08-05 — a deliberate signal that the long Las Vegas-style wait for a leasing bottom may be over. The Studio Plaza repositioning, which has been a drag on occupancy for years, is now more than 50% leased and has been moved into the in-service portfolio. As CFO Peter Seymour noted, the move "will have the effect of widening our lease to occupied spread for the next few quarters," but Jordan Kaplan doesn't see that as a bad thing: “I would tell you, when that spreads wide, we are leasing a lot” — Jordan L. Kaplan, Chairman and CEO · 2026-08-05. The spread sits at over 470 basis points, a level Kaplan calls "extremely good" — and a far cry from the troughs seen in 2025.
Acquisitions: A Seller's Market for Buyers Like DEI
The bigger strategic shift is the appetite for acquisition. After years of emphasizing residential development, Kaplan made clear that today's market offers a rare window:
That conviction is backed by action — the company and its joint-venture partners closed the Bedford Collection, a 246k square-foot medical office portfolio in the Beverly Hills Golden Triangle. This marks DEI's return to its roots in sticky, supply-constrained office product, and Kaplan's love for it is palpable: “We are working on a bunch of acquisitions... I love buying deals at good pricing” — Jordan L. Kaplan, Chairman and CEO · 2026-08-05. He even hinted at all-in cash IRRs in the low-teens, a level not seen since previous cycles.I was surprised the stock was off because we were talking about, I am like, it is the best time to be in real estate.
The Interest Rate Headwind
The one sour note remains the cost of debt. DEI refinanced over $800 million of loans this quarter at effective fixed rates near 6.15–6.18%, but that still jumps from the ~3% average the company enjoyed for years. Interest expense rose 7% year over year, and management guided 2026 FFO to $1.39–$1.43, below prior estimates, solely because of higher assumed rates. Cap rates on office acquisitions may be enticing, but the carry on the existing portfolio is a drag. Kaplan was candid: “There might be ways especially with the fact that we are buying at same time and bringing in partners to reduce our exposure” — Jordan L. Kaplan, Chairman and CEO · 2026-08-05. He hinted at more permanent solutions — lower leverage, asset sales, or creative JV structures — to rightsize the balance sheet while rates stay elevated.
What the Numbers Say
The fundamentals confirm the operational recovery but expose the interest burden. Net margin swung to -5.0% in Q2 2026, driven by a ~$13M net loss, while interest coverage slipped to 0.9x — a red flag if not for the large cushion of unencumbered assets and JV flexibility. Yet operating cash flow remains robust at $117M, and the recent stock surge of +21.8% over 90 days suggests investors are finally giving credit to the leasing momentum. The company's medical office expansion into Beverly Hills is a strategic bet on demographics and tenant stickiness, and the JV structure keeps additional leverage off the parent balance sheet. As Kaplan said on a prior call, “Our leasing is really picking up” — Jordan Kaplan, Chairman and CEO · 2026-05-06 — and if that continues, the interest headwind may eventually become a minor footnote in an otherwise strong recovery story.